Published in Biochemistry on June 20, 2000
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Liver fatty acid-binding protein and obesity. J Nutr Biochem (2010) 1.59
The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics (2011) 1.57
Structural and functional analysis of fatty acid-binding proteins. J Lipid Res (2008) 1.56
Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem (2010) 1.52
Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins. J Med Chem (2009) 1.32
Shotgun proteomics analysis of hibernating arctic ground squirrels. Mol Cell Proteomics (2009) 1.20
Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J Biol Chem (2011) 1.17
Epoxyeicosatrienoic acid analogs and vascular function. Curr Med Chem (2010) 1.11
Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer (2004) 1.10
Hepatic phenotype of liver fatty acid binding protein gene-ablated mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.04
Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J (2001) 1.03
Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis. Am J Physiol Gastrointest Liver Physiol (2011) 1.01
Structural and functional characterization of human peripheral nervous system myelin protein P2. PLoS One (2010) 1.01
Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry (2006) 1.00
Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics. PLoS One (2012) 0.99
Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mol Cell Biol (2003) 0.97
Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res (2014) 0.94
Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids. J Neurochem (2008) 0.92
Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine. Prostaglandins Leukot Essent Fatty Acids (2014) 0.91
Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor β/δ (FABP5-PPARβ/δ) signaling pathway. J Biol Chem (2014) 0.90
Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding protein. J Biol Chem (2010) 0.89
Water-mediated recognition of simple alkyl chains by heart-type fatty-acid-binding protein. Angew Chem Int Ed Engl (2014) 0.88
Diverse roles of SIRT1 in cancer biology and lipid metabolism. Int J Mol Sci (2015) 0.88
Mechanisms involved in the selective transfer of long chain polyunsaturated Fatty acids to the fetus. Front Genet (2011) 0.85
Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding. J Biol Chem (2013) 0.83
Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner. J Biol Chem (2015) 0.83
The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon. Nutr Rev (2011) 0.82
Fatty acid binding proteins have the potential to channel dietary fatty acids into enterocyte nuclei. J Lipid Res (2015) 0.79
Molecular mechanism by which palmitate inhibits PKR autophosphorylation. Biochemistry (2011) 0.79
Molecular modeling and functional confirmation of a predicted fatty acid binding site of mitochondrial aspartate aminotransferase. J Mol Biol (2011) 0.79
The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression. Lipids Health Dis (2008) 0.77
Concerted dynamic motions of an FABP4 model and its ligands revealed by microsecond molecular dynamics simulations. Biochemistry (2014) 0.77
FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity. J Biol Chem (2014) 0.77
Comparative study of the fatty acid binding process of a new FABP from Cherax quadricarinatus by fluorescence intensity, lifetime and anisotropy. PLoS One (2012) 0.77
The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols. Genes Nutr (2012) 0.75
Towards an understanding of Mesocestoides vogae fatty acid binding proteins' roles. PLoS One (2014) 0.75
Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J Biol Chem (1980) 3.20
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology (2001) 2.49
The concept of lipid domains in membranes. J Cell Biol (1982) 2.26
DNA-binding site of lac repressor probed by dimethylsulfate methylation of lac operator. J Mol Biol (1979) 2.20
New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18
Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J (1999) 2.07
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem (1998) 1.97
Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry (1993) 1.88
Unbound free fatty acid levels in human serum. J Lipid Res (1995) 1.88
Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia (1994) 1.69
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol (1999) 1.66
Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem (1994) 1.64
A fluorescently labeled intestinal fatty acid binding protein. Interactions with fatty acids and its use in monitoring free fatty acids. J Biol Chem (1992) 1.57
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Elastin as a biomaterial for tissue engineering. Biomaterials (2007) 1.53
A radiochemical procedure for the assay of fatty acid binding by proteins. Anal Biochem (1983) 1.52
Three-dimensional structure of recombinant human muscle fatty acid-binding protein. J Biol Chem (1992) 1.49
A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46
The use of primidone in neonates with theophylline-resistant apnea. Am J Dis Child (1993) 1.40
Nucleotide sequence analysis of the complement resistance gene from plasmid R100. J Bacteriol (1982) 1.38
Quantitative analysis of EEG in boys with attention-deficit-hyperactivity disorder: controlled study with clinical implications. Pediatr Neurol (1992) 1.37
Intracellular fatty acid-binding proteins. Int J Biochem (1985) 1.36
Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J (1992) 1.35
Fatty acid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol (1971) 1.35
Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids. Structure (1994) 1.29
Elimination of autofluorescence in immunofluorescence microscopy with digital image processing. J Histochem Cytochem (1995) 1.25
Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials (1999) 1.25
Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res (2002) 1.23
14CO2 production is no adequate measure of [14C]fatty acid oxidation. Biochem Med Metab Biol (1986) 1.22
Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials (2001) 1.22
Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100. J Immunol (1980) 1.21
Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5. J Immunol (2000) 1.21
Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J (1991) 1.20
Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta (1988) 1.20
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int (1992) 1.19
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry (2001) 1.19
cDNA clone spanning the alpha-gamma subunit junction in the precursor of the murine fourth complement component (C4). Proc Natl Acad Sci U S A (1983) 1.19
Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials (2000) 1.18
Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics (1977) 1.18
Primary structure of the fifth component of murine complement. Biochemistry (1987) 1.16
Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci (2000) 1.16
Complete cDNA sequence of the fourth component of murine complement. Proc Natl Acad Sci U S A (1985) 1.16
The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: a practical guide for the use of the ADIFAB probe. Mol Cell Biochem (1999) 1.15
Kinetics of fatty acid interactions with fatty acid binding proteins from adipocyte, heart, and intestine. J Biol Chem (1996) 1.15
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun (1990) 1.14
Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes. Proc Natl Acad Sci U S A (1986) 1.13
Methylphenidate therapy for aggression in a man with ring 22 chromosome. Report and literature review. Arch Neurol (1985) 1.12
Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta (1985) 1.11
The activity state of the branched-chain 2-oxo acid dehydrogenase complex in rat tissues. Biochem J (1984) 1.11
Transfer of long-chain fluorescent free fatty acids between unilamellar vesicles. Biochemistry (1986) 1.11
The binding of a spin-labeled triphosphate to hemoglobin. Cold Spring Harb Symp Quant Biol (1972) 1.10
Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia (2000) 1.10
Energy-transfer study of cytochrome b5 using the anthroyloxy fatty acid membrane probes. Biochemistry (1985) 1.10
Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol (2001) 1.09
Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA. Proc Natl Acad Sci U S A (1984) 1.09
Pyruvate oxidation in rat and human skeletal muscle mitochondria. Biochem Med (1978) 1.09
Diurnal variation of cytosolic fatty acid-binding protein content and of palmitate oxidation in rat liver and heart. J Biol Chem (1984) 1.08
Murine sex-limited protein: complete cDNA sequence and comparison with murine fourth complement component. J Immunol (1985) 1.08
Investigation of mitochondrial metabolism in small human skeletal muscle biopsy specimens. Improvement of preparation procedure. Clin Chim Acta (1985) 1.08
Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium. In Vitro Cell Dev Biol Anim (1999) 1.07
Behavioral correlates in the happy puppet syndrome: a characteristic profile? Dev Med Child Neurol (1981) 1.07
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int (1993) 1.07
States of hemoglobin in solution. Biochemistry (1972) 1.07
The effect of malonyl-CoA on fatty acid oxidation in rat muscle and liver mitochondria. Biochim Biophys Acta (1982) 1.06
Thermodynamics of fatty acid binding to fatty acid-binding proteins and fatty acid partition between water and membranes measured using the fluorescent probe ADIFAB. J Biol Chem (1995) 1.06
Mechanism of cooperative oxygen binding to hemoglobin (spin-labeled triphosphate-concerted transition model-hemoglobin chesapeake). Proc Natl Acad Sci U S A (1972) 1.05
Incomplete palmitate oxidation in cell-free systems of rat and human muscles. Biochim Biophys Acta (1983) 1.05
Membrane partition of fatty acids and inhibition of T cell function. Biochemistry (1993) 1.05
Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther (2007) 1.05
Effect of genetic variants of the heart fatty acid-binding protein gene on intramuscular fat and performance traits in pigs. J Anim Sci (1999) 1.04
Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem (1994) 1.04
The superfamily of C3b/C4b-binding proteins. Fed Proc (1987) 1.04
Fatty-acid-binding proteins do not protect against induced cytotoxicity in a kidney cell model. Biochem J (2001) 1.03
Effect of starvation and exercise on actual and total activity of the branched-chain 2-oxo acid dehydrogenase complex in rat tissues. Biochem J (1984) 1.03
Characterization and binding properties of fatty acid-binding proteins from human, pig, and rat heart. Arch Biochem Biophys (1988) 1.02
cDNA structure of murine C4b-binding protein, a regulatory component of the serum complement system. Biochemistry (1987) 1.01
The C4 and Slp genes of the complement region of the murine H-2 major histocompatibility complex. Philos Trans R Soc Lond B Biol Sci (1984) 1.01
Tryptophan imaging of membrane proteins. Biochemistry (1985) 1.01
Hypomyelination in copper-deficient rats. Prenatal and postnatal copper replacement. Arch Neurol (1976) 1.01
Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol (1994) 1.01
Fatty acid-binding proteins of nervous tissue. J Mol Neurosci (2001) 1.01
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord (2001) 0.99
Endothelial cells of the human microvasculature express epidermal fatty acid-binding protein. Circ Res (1997) 0.99
The binding affinity of fatty acid-binding proteins from human, pig and rat liver for different fluorescent fatty acids and other ligands. Int J Biochem (1989) 0.99
The composition of the cell wall of Lactobacillius bifidus var. pennsylvanicus. Arch Biochem Biophys (1965) 0.98
Comparison of the phospholipid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol (1971) 0.98
Purification and characterization of fatty-acid-binding proteins from rat heart and liver. Biochim Biophys Acta (1985) 0.98
Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials (2000) 0.97
Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials (2003) 0.97
Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells. J Clin Invest (1997) 0.97
Structure of the lipoteichoic acids from Bifidobacterium bifidum spp. pennsylvanicum. Biochim Biophys Acta (1984) 0.97
Spin-labeled hemoglobin derivatives in solution, polycrystalline suspensions, and single crystals. Biochemistry (1969) 0.97
Lipid domains in membranes. Ann N Y Acad Sci (1982) 0.97
Traumatic vertebrobasilar occlusive disease in childhood. Neurology (1978) 0.97